13 Jan 2020
Phase II clinical trial of respiratory drug for treatment of Parkinson’s disease reveals promising results
//
Comments0
/NOTE: This release was originally published by The Cure Parkinson’s Trust. Results published today in the Journal of the American Medical Association...Read More
30 Jan 2019
Australian Government invests in innovative genomic testing in Linked Clinical Trials program
This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here. It was announced today that the...Read More
11 Oct 2018
ICYMI: Three big takeaways from Grand Challenges in Parkinson’s Disease
Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a...Read More
25 Sep 2017
Van Andel Research Institute hosts unique symposium on Parkinson’s disease
Patients join scientists and clinicians to explore ways to slow Parkinson’s progression Grand Rapids, Mich. (Sept. 25, 2017)—Leading Parkinson’s experts and advocates...Read More
30 Dec 2016
What difference does a year make?
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel...Read More
12 Jul 2016
Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease
Note: To read the commentary published in the Journal of Parkinson’s Disease click here. Investigators will focus on safety for long-term use in non-cancer...Read More
23 Sep 2014
Van Andel Research Institute joins The Cure Parkinson’s Trust to accelerate development of new Parkinson’s disease treatments
Grand Rapids, Mich. (Sept. 23, 2014) – Van Andel Research Institute (VARI) has partnered with UK-based research charity The Cure Parkinson’s Trust on...Read More
7 Aug 2014
Rallying to the Challenge meeting aims to improve Parkinson’s disease clinical trials
Meeting held in Grand Rapids, Mich., aims to increase the effectiveness and efficiency of the Parkinson’s disease clinical trial system Grand Rapids,...Read More